NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+30.31%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.24B
AUM Growth
+$1.24B
(+21%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
95.45%
Holding
16
New
3
Increased
3
Reduced
2
Closed
1
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$84.9M |
| 2 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$22.8M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$12.3M |
| 4 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$10.1M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$2.52M |
Top Sells
| 1 |
Inogen
INGN
|
$58.7M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$44.6M |
| 3 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$19.9M |
Sector Composition
| 1 | Healthcare | 57.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Total Stock Market ETF
VTI
$526B
| $316M | 25.55% | 2,979,100 | – | – |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $265M | 21.42% | 5,901,819 -995,000 | -14% | -$44.6M |
|
|
3
Inogen
INGN
$216M
| $111M | 9.01% | 3,549,320 -1,870,129 | -35% | -$58.7M |
|
4
Vanguard FTSE Europe ETF
VGK
$26.8B
| $110M | 8.91% | 2,101,000 | – | – |
|
|
ALDR
5
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $93.1M | 7.53% | 3,201,183 | – | – |
|
|
NVRO
6
DELISTED
NEVRO CORP.
NVRO
| $84.9M | 6.87% | +2,194,841 | New | +$84.9M |
|
|
OTIC
7
DELISTED
Otonomy, Inc.
OTIC
| $72.5M | 5.86% | 2,175,025 | – | – |
|
|
TTPH
8
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $58.6M | 4.74% | 1,475,000 +575,000 | +64% | +$22.8M |
|
|
FLXN
9
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $46.1M | 3.73% | 2,283,131 +500,000 | +28% | +$10.1M |
|
10
Akebia Therapeutics
AKBA
$833M
| $17.7M | 1.43% | 1,516,387 | – | – |
|
11
Eledon Pharmaceuticals
ELDN
$155M
| $17.4M | 1.41% | 1,178,992 +103,955 | +10% | +$1.53M |
|
|
AERI
12
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $12.3M | 0.99% | +419,652 | New | +$12.3M |
|
|
XENT
13
DELISTED
Intersect ENT, Inc
XENT
| $6.49M | 0.53% | 350,000 | – | – |
|
|
14
Xenon Pharmaceuticals
XENE
$2.98B
| $2.52M | 0.2% | +127,563 | New | +$2.52M |
|
|
ZSPH
15
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| – | – | -506,730 | Closed | -$19.9M |
|